• Publications:
• Consolidation ipilimumab and nivolumab vs observation in limited stage SCLC after chemo-radiotherapy: Results from the ETOP/IFCT 4-12 STIMULI trial
• Consolidation nivolumab and ipilimumab versus observation in limited-disease small-cell lung cancer after chemo-radiotherapy - results from the randomised phase II ETOP/IFCT 4-12 STIMULI trial
• Synopsis: ETOP-IFCT_4-12_STIMULI_Amendment_1_Synopsis_FR_v2.0_150803.pdf